This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Bristol Myers Beats on Earnings, Cancer Drug Sales Disappoint

Drug maker Bristol Myers (BMY) posted earnings of $0.71 per share on Tuesday, beating analyst estimates.

Volatility Spikes as Consumer Confidence Slides; Coach Drags

Stocks had yo-yoed from minor gains to a sharp drop and back again by midday Tuesday.

UPS Profit Jumps as Price Hikes and Domestic Growth Fuel Revenue

UPS (UPS) delivered strong first quarter earnings that beat estimates but missed on revenue.

Verifone CEO on Apple Pay & Growth in Payments Space

TheStreet's Scott Gamm speaks with Paul Galant, CEO of Verifone (PAY), to discuss the company's partnership with Apple (AAPL) and how mobile devices are changing the payments space.

Pfizer Tops Estimates but Cuts 2015 Outlook Due to Strong Dollar

Pfizer's (PFE) new drugs pipeline gave their first quarter earnings a boost on Tuesday.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Submit an article to us!

Markets

DOW 18,086.01 +48.04 0.27%
S&P 500 2,111.50 +2.58 0.12%
NASDAQ 5,064.4030 +4.1570 0.08%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs